Forward Citations = 284

Loading Chart...

4 inventors (with patents filed for the assignee):

Bernhard O Palsson (5 out of 50 patents)

Manfred Koller (5 out of 14 patents)

Timothy M Eisfeld (5 out of 14 patents)

4. Elie G Hanania (1 out of 5 patents)

5 patents: Sort by Forward Citations

1. 6804385 - Method and device for selectively targeting cells within a three-dimensional specimen (2004-10-12),

2. 6753161 - Optoinjection methods (2004-06-22),

3. 6642018 - Method for inducing a response in one or more targeted cells (2003-11-04),

4. 6534308 - Method and apparatus for selectively targeting specific cells within a mixed cell population (2003-03-18),

5. 6514722 - Method and apparatus for selectively targeting specific cells within a cell population (2003-02-04),

Oncosis is a biopharmaceutical company focused on developing innovative therapies for cancer. With a strong emphasis on research and development, Oncosis is dedicated to finding novel approaches to treating cancer that target specific pathways and mechanisms of the disease. Through collaborations with leading oncology experts and institutions, Oncosis aims to bring new and effective treatments to patients in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

5 Patents

#872 in San Diego, CA

#12,032 in California

#51,478 in US

San Diego, CA, United States of America

Oncosis

Forward Citations = 284

4 inventors:

Bernhard O Palsson (5 out of 50 patents)

Manfred Koller (5 out of 14 patents)

Timothy M Eisfeld (5 out of 14 patents)

4. Elie G Hanania (1 out of 5 patents)

Please report any incorrect information to [email protected]